Scott M Whitcup
CIK 1298941 · Executive VP, R&D, CSO · last filed 2025-12-10
Scott M Whitcup is an Executive VP, R&D, CSO who has filed 71 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for ADVM, was dated Dec 10, 2025. Across all open-market trades the lifetime net is −$34.4M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
6
71
-$34.40M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies, Inc. (ADVM) Delisted | Director | — | $4.36 | — | $0 | 8 | 2025-12-10 |
| VYNE Therapeutics Inc. (MNLO) Delisted | Director | — | — | — | $0 | 3 | 2019-08-08 |
| NITE | Director | 0 | $37.45 | $0 | $0 | 2 | 2019-06-07 |
| ALLERGAN INC (AGN) Delisted | Executive VP, R&D, CSO | 18,964 | — | — | -$34.40M | 46 | 2015-02-24 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | 4,183 | — | — | $0 | 3 | 2013-05-29 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Director | 306,494 | — | — | $0 | 7 | 2013-02-19 |
Recent Filings
71 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-10 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-06-20 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-20 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-13 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-14 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-14 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-25 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-20 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-08-08 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-27 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | — | $0 | EDGAR |